ArticleHealth services research2026
Early Examination of Hospital-Level Performance on Unplanned, Potentially Avoidable Hospital Visits After Chemotherapy, 2018-2022.
Article in Health services research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early Examination of Hospital-Level Performance on Unplanned, Potentially Avoidable Hospital Visits After Chemotherapy, 2018-2022.Health services research · 2026Article
- Dissonance in the Sole Quality Measure for Outpatient Chemotherapy, OP-35.JCO clinical cancer informatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo assess changes in publicly reported, potentially avoidable hospital visits after chemotherapy since the introduction of a Medicare quality measure. STUDY SETTING AND
designRetrospective analysis of avoidable emergency department (ED) and inpatient admission (ADM) rates after chemotherapy between 2018 and 2022, across absolute visit rates and relative hospital performance ("better than", "no different than", "worse than" the national rate). We stratified hospitals into quartiles of visit rates in 2018 and used this to model the change in visit rates from 2018 to 2022 with generalized linear regression. DATA SOURCES AND ANALYTIC SAMPLE: A longitudinal cohort of hospitals from the Medicare Outpatient Quality Reporting Program. PRINCIPAL
findingsWe analyzed 1179 hospitals (94.3% non-profit, 22.9% teaching). National avoidable ED visit rates were 6.0% in 2018, 5.4% in 2022; ADM rates were 12.5% in 2018, 10.3% in 2022. Nearly all hospitals were deemed to have performed "no different" than the national rate each year in ED (≥ 95.3%) and ADM (≥ 91.1%). In adjusted analyses, visit rates for hospitals in the lowest 2018 visit rate quartiles declined the least by 2022 (ED: -0.44% 95% CI: -0.58 to -2.94; ADM: -0.91%, 95% CI: -1.14 to -0.69), and declined the most for hospitals in the highest 2018 quartiles (ED: -1.72%, 95% CI: -1.85 to -7.73; ADM: -3.03%, 95% CI: -3.27 to -2.81). We estimated that the tendency for extreme baseline values to approach the average over time accounted for up to one-tenth of the decline among the worst-performing 2018 quartiles (ED: 10.6% of rate change, 95% CI: 9.8 to 11.5; ADM: 9.0%, 95% CI: 8.2 to 9.8).
conclusionHospitals reduced their potentially avoidable hospital visit rates, though Medicare deemed that nearly all hospitals performed "no different" than the national average each year. It remains unclear if the reductions were driven by this quality measure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.